Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
07/2000
07/12/2000CN1259343A Air pressed package using polyoxyethylene glyceryl oleate
07/12/2000CN1259342A Air pressed package using polyoxyethylene glyceryl oleate
07/12/2000CN1054282C Stabilized medicinal aerosol solution formulations
07/12/2000CN1054280C Non-pharmaceutical skin-care composition
07/06/2000WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same
07/06/2000WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors
07/06/2000WO2000039125A1 Piperidines as ccr5 modulators
07/06/2000WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands
07/06/2000WO2000038727A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
07/06/2000WO2000038725A1 Combinations for cardiovascular indications
07/06/2000WO2000038701A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine
07/06/2000WO2000038680A1 Azabicycloalkanes as ccr5 modulators
07/06/2000WO2000038617A2 Compositions and methods of using the same
07/06/2000WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy
07/06/2000CA2356840A1 Compositions and methods of using the same
07/06/2000CA2356607A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
07/06/2000CA2356515A1 Combinations for cardiovascular indications
07/06/2000CA2356098A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine
07/05/2000EP1016419A2 Non-invasive localization of a light-emitting conjugate in a mammal
07/05/2000EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
07/05/2000EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
07/05/2000EP1014931A1 Cleansing compositions
07/05/2000EP1014920A1 Conditioning shampoo composition comprising pentaerythritol ester oil
07/05/2000EP1014919A1 Hair conditioning composition comprising high molecular weight ester oil
07/05/2000EP0554436B1 Gaba receptor modulators
07/05/2000CN1259143A Oligosaccharide mixtures having antithrombotic activity
07/05/2000CN1259040A Compositions and methods for inhibiting photoaging of skin
07/04/2000US6083938 Pyridinylbisphosphonates for use as a therapeutical agent
07/04/2000US6083922 Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
07/04/2000US6083722 Borrelia antigen
07/04/2000US6083485 Near infrared radiation in-vivo diagnostic methods and dyes
06/2000
06/29/2000WO2000037646A2 Group b streptococcus proteins, and their use
06/29/2000WO2000037106A1 Oral vaccine against diarrhea
06/29/2000WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
06/29/2000WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
06/29/2000WO2000037040A1 Skin care compositions containing cis-9, trans-11 linoleic acid
06/29/2000WO2000037024A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
06/29/2000WO2000016757A8 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2352309A1 Oral vaccine against diarrhea
06/28/2000EP1013278A1 The extract of pine needle and the use thereof
06/28/2000EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000EP1011684A2 Solid oral dosage form comprising a combination of metformin and glibenclamide
06/28/2000EP1011673A1 Novel niddm regimen
06/28/2000EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011646A1 Pharmaceutical compositions and devices for their administration
06/28/2000EP1011625A1 Cleansing compositions
06/28/2000EP1011614A1 Hair care compositions comprising optical brighteners which provide uv protection
06/28/2000CN1258295A Novel form of S-omeprazole
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/28/2000CN1053838C Synergism of TNF and IL-4
06/22/2000WO2000035461A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
06/22/2000WO2000035434A2 Compositions and methods for the treatment of anorectal disorders
06/22/2000WO2000035425A1 STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
06/22/2000WO2000012045A3 Method for treating neurodegenerative disorders
06/22/2000CA2355775A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
06/22/2000CA2354543A1 Compositions and methods for the treatment of anorectal disorders
06/21/2000EP1009371A1 Denture cleansing composition
06/21/2000EP1009369A1 Oral compositions
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers
06/21/2000CN1257431A Chemically and thermally stable norastemizole formulations
06/20/2000US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/20/2000US6076777 Positioning device for a mobile phone
06/17/2000CA2290880A1 Cosmetic skin care compositions containing succinate compounds
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034283A1 Novel triazolo(4,5-d)pyrimidine compounds
06/15/2000WO2000034263A1 Benzofuran derivatives, their preparation and use
06/15/2000WO2000033878A2 Stabilization of macrolides
06/15/2000WO2000033819A1 Method for producing agglomerates comprising a core-shell structure
06/15/2000WO2000033805A1 Cosmetic skin care compositions containing 4-chromanone
06/15/2000WO2000033801A1 Striped dentifrice
06/15/2000WO2000033789A2 Inhalation powders
06/15/2000DE19856149C1 Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur A process for producing agglomerates with a core-shell structure
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2353618A1 Benzofuran derivatives, their preparation and use
06/15/2000CA2353104A1 Cosmetic skin care compositions containing 4-chromanone
06/15/2000CA2351390A1 Thiourea inhibitors of herpes viruses
06/14/2000EP1008344A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/14/2000EP1007103A2 Process for preparation of lyophilised contrast agents
06/14/2000EP1007102A1 Process for preparing contrast agents
06/14/2000EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents
06/14/2000EP1007060A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
06/14/2000EP1007053A1 Treatment of pain
06/14/2000EP1007017A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
06/14/2000EP1007008A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
06/14/2000CN1256630A Parvitamin A correlation molecule for treating non-insulin dependent diabetes mellitus (NIDDM)
06/14/2000CN1053341C Use of nadh and nadph or their salts in pharmaceutic
06/13/2000US6074653 Topical applicable
06/13/2000US6074648 Galenic preparation for prevention and treatment of hepatocarcinoma
06/13/2000CA2125667C Fluorocarbon aerosol medicaments
06/08/2000WO2000032616A1 Hygromycin a derivatives as antibacterial agents
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032567A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000WO2000032228A2 Peptide-based vaccine for influenza
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 295